Close Menu

NEW YORK – Abbott said after the close of the market on Friday that the US Food and Drug Administration issued Emergency Use Authorization for the company's point-of-care test for detection of SARS-CoV-2.

According to the Abbott Park, Illinois-based firm, the test, which will run on its ID Now platform, can provide positive results in as little as five minutes and negative results in 13 minutes, and it can be used in a variety of healthcare settings, including doctors' offices, urgent care clinics, and hospital emergency departments.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.